LYTIR

Insider · SEC Form 4 · Chief Financial Officer

STEPHENSON BRIAN C

In the 12 months to Nov 8, 2026, on the open market: bought $1.1M of FTH. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $1.1M in total; Insider sales: $0 in total.Jun: Insider purchases $1.0MJul: Insider purchases $117KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $1.1MInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. FTHBought: Faeth Therapeutics, Inc. Jul 1, 2026 5,000 shares filed Jul 1, 2026 2 transactions filing $117K
  2. FTHBought: Faeth Therapeutics, Inc. Jun 30, 2026 7,803 shares filed Jul 1, 2026 3 transactions filing $189K
  3. FTHBought: Faeth Therapeutics, Inc. Jun 29, 2026 831 shares filed Jul 1, 2026 33,885 shares held indirectly after, as filed filing $19K
  4. FTHBought: Faeth Therapeutics, Inc. Jun 26, 2026 6,250 shares filed Jun 26, 2026 4 transactions filing $156K
  5. FTHBought: Faeth Therapeutics, Inc. Jun 24, 2026 9,391 shares filed Jun 26, 2026 4 transactions filing $245K
  6. FTHBought: Faeth Therapeutics, Inc. Jun 23, 2026 9,230 shares filed Jun 24, 2026 3 transactions filing $225K
  7. FTHBought: Faeth Therapeutics, Inc. Jun 22, 2026 8,183 shares filed Jun 24, 2026 5 transactions filing $181K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.